2 Stories in coverage 1 Program 11 recruiting Registered trial 8-K Oct 1 Latest SEC filing Sep 22 Latest story
Timeline 2 Pipeline 1 Trials 1
Pipeline by stage
Phase 2 1
Details
Headquarters Tel Aviv Incorporated Israel Industry Pharmaceutical Preparations Formerly Enlivex Therapeutics Ltd. (to 2026); Bioblast Pharma Ltd. (to 2019); BIO BLAST PHARMA LTD. (to 2016) Also known as BIO BLAST PHARMA LTD., Bioblast Pharma Ltd., Enlivex Ltd., ENLV How the company describes itself Enlivex develops Allocetra, an immunotherapy in clinical trials for inflammatory conditions associated with aging, including age-related osteoarthritis. The company also operates a prediction markets treasury strategy. source
Sign in